Versionen im Vergleich

Schlüssel

  • Diese Zeile wurde hinzugefügt.
  • Diese Zeile wurde entfernt.
  • Formatierung wurde geändert.
Kommentar: Migration of unmigrated content due to installation of a new plugin

Bacteria incl. Archaea

Enterococcus hirae

Strain/Type

Enterococcus hirae Farrow and Collins 1985

DSM No.: 3320

Strain designation: M 19

Other collection no. or WDCM no.: ATCC 10541, CIP 58.55, NCIB 8192, WDCM 00011, NBRC 113010

Source/Company

Prof. Dr. Elisabeth Grohmann, BHT, Fachbereich V Life Sciences und Technology, Labor für Mikrobiologie, Forum Seestraße, Seestraße 64, 2. OG, Raum 275, Tel.: +49 030 4504-3942

Usage Regulation and Limitations

Acknowledge Prof. Dr. Elisabeth Grohmann (BHT, Fachbereich V Life Sciences und Technology, Labor für Mikrobiologie) in any publication.

How to cite

Acknowledge Prof. Dr. Elisabeth Grohmann (BHT, Fachbereich V Life Sciences und Technology, Labor für Mikrobiologie) in any publication.

Host tropism

human and other vertebrates

Route of Transmission

oral

Characteristics e.g. sensitizing or toxic effects, resistance to antibiotics

Note ht:

Pathogenic for humans and vertebrates, but normally no transmission between the two host groups.

Approved as biological safety measure if taken as recipient organism for genetic engineering?

Genetically modified (GenTSV)

no

Risk group (BioStoffV)

2 

Risk assessment

classification according to German TRBA)Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1

Operation instructions (mandatory for RG2 and higher)

View file
nameEnterococcus hirae_Biostoffdokument-822271.pdf
height250
View file
nameEnterococcus hirae_Biostoffdokument-822271_en.pdf
height250

Occupational health care (according to ArbMedVV)

Optional health care:

In the case of tasks specifically involving contact and tasks involving incidental contact with biological agents classed as Risk Group 2 under the Biological Agents Ordinance (Biostoffverordnung, BioStoffV) or which involve a comparable risk, the employer must offer an optional health care. This does not apply when on account of the risk assessment and on account of the protective measures taken it can be assumed that there is no risk of infection.

An optional health care must also be offered if as a result of the exposure to biological agents

- a serious infectious illness is to be expected and post-exposure prophylatic measures are possible,

or

- an infection has resulted.

Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)

sourcebacterial strainfreezing dateamount of bacteria  per vialstock was produced onno. of aliquotsbelongs to
(full name)

rack/box in N2 tank or -80°C freezer and  location (room, address)


comments

Cultivation and freezing protocols

Medium 92 , 37°C
or
Medium 693 , 37°C
Incubation time: 1-2 days
Please follow special instructions: 'Cultivation of Streptococci and Enterococci'
Complete DSMZ Media List

Data sheets, further information

View file
nameEnterococcus hirae_Leibniz Institute DSMZ_3320Details.pdf
height250